HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1- (3- benzyl- 2- imino- 2,3- dihydro- 1H- benzo(d)imidazol- 1- yl)- 3- (p- tolyloxy)propan- 2- ol

structure in first source

Also Known As:

VU573

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzimidazoles: 245
      - 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo(d)imidazol-1-yl)-3-(p-tolyloxy)propan-2-ol: 1
Organic Chemicals: 133
- Imines: 310
  - 1-(3-benzyl-2-imino-2,3-dihydro-1H-benzo(d)imidazol-1-yl)-3-(p-tolyloxy)propan-2-ol: 1

Experts

1.	Beyenbach, Klaus W: 1 article (10/2014)
2.	Denton, Jerod: 1 article (10/2014)
3.	Hine, Rebecca M: 1 article (10/2014)
4.	Park, Seokhwan Terry: 1 article (10/2014)
5.	Piermarini, Peter M: 1 article (10/2014)
6.	Raphemot, Rene: 1 article (10/2014)
7.	Rouhier, Matthew F: 1 article (10/2014)

Related Diseases

1.	Yellow Fever 10/01/2014 - "The effect of two small molecules VU342 and VU573 on renal functions in the yellow fever mosquito Aedes aegypti was investigated in vitro and in vivo. "